MM and Thrombosis: Prophylaxis and Risk Prediction Tools
This review aims to make clear the need for the development of more accurate risk assessment tools and means of thrombosis prevention. Recently, several groups developed clinical scores for thrombosis risk in multiple myeloma to improve risk stratification, and research in this field is focusing on understanding the unique coagulation profile of the multiple myeloma patient. Thromboembolism in multiple myeloma patients remains a common complication that renders the optimization of thromboprophylaxis.
Reference: Fotiou, D, Gavriatopoulou, M, et al. Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools. Cancers. 2020 Jan; 12(1): 191.
